PTX-COVID19-B
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for PTX-COVID19-B, covering 2022-09-09 to 2023-04-07. Get the full timeline:
Most recent: Clinical Trial Update: PTX-COVID19-B, an mRNA Humoral Vaccine, Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Demonstrate the Safety, Tolerability, and Immunogenicity of PTX-COVID19-B in Comparison to the Pfizer-BioNTech COVID-19 Vaccine. [Phase 2]